Trial intelligence / Profile preview

Remifentanil versus propofol-based ICU sedation in mechanically ventilated adults

2006-004204-39Phase 3Terminated

Sponsor
GSK
Start
Jan 2007
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in critical illness comparing Analgesia-based remifentanil regimen with Conventional sedation-based propofol regimen (2 arms). Primary endpoint: Duration of time on mechanical ventilation. Started Jan 2007; status: terminated.

02

Drugs

remifentanilpropofol
03

Conditions

critical illness

Beyond the preview

Go deeper on 2006-004204-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004204-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call